Cecilia Sepulveda

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi Quality care at the end of life in Africa
    Cecilia Sepulveda
    Programme on Cancer Control, World Health Organization, Avenue Appia 20, CH-1211 Geneva 27, Switzerland
    BMJ 327:209-13. 2003
  2. ncbi Desirable services and guidelines for the treatment and palliative care of HIV disease patients with cancer in Africa: a World Health Organization consultation
    Charles Olweny
    St. Boniface General Hospital, Winnipeg, Canada
    J Palliat Care 19:198-205. 2003
  3. ncbi Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis
    Gary M Ginsberg
    Costs, Effectiveness, Expenditure and Priority Setting, World Health Organization, Geneva, Switzerland
    Cost Eff Resour Alloc 8:2. 2010
  4. ncbi Effective cervical cytology screening programmes in middle-income countries: the Chilean experience
    Cecilia Sepulveda
    WHO Programme on Cancer Control, Geneva, Switzerland
    Cancer Detect Prev 29:405-11. 2005
  5. ncbi Palliative Care: the World Health Organization's global perspective
    Cecilia Sepulveda
    Program on Cancer Control, World Health Organization, Geneva, Switzerland
    J Pain Symptom Manage 24:91-6. 2002
  6. ncbi Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis
    Gary Michael Ginsberg
    World Health Organization, Health Systems Financing Department, Costs, Effectiveness, Expenditure and Priority Setting Unit, Geneva, Switzerland
    Vaccine 27:6060-79. 2009
  7. ncbi Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients
    Ivan Palomo
    Department of Clinical Biochemistry and Immunohematology, Faculty of Health Sciences, University of Talca, Talca, Chile
    J Clin Lab Anal 17:209-15. 2003

Collaborators

Detail Information

Publications7

  1. ncbi Quality care at the end of life in Africa
    Cecilia Sepulveda
    Programme on Cancer Control, World Health Organization, Avenue Appia 20, CH-1211 Geneva 27, Switzerland
    BMJ 327:209-13. 2003
  2. ncbi Desirable services and guidelines for the treatment and palliative care of HIV disease patients with cancer in Africa: a World Health Organization consultation
    Charles Olweny
    St. Boniface General Hospital, Winnipeg, Canada
    J Palliat Care 19:198-205. 2003
  3. ncbi Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis
    Gary M Ginsberg
    Costs, Effectiveness, Expenditure and Priority Setting, World Health Organization, Geneva, Switzerland
    Cost Eff Resour Alloc 8:2. 2010
    ..CONCLUSIONS: From a cost-effectiveness standpoint, screening programmes should be expanded in developed regions and treatment programmes should be established for colorectal cancer in regions with low treatment coverage...
  4. ncbi Effective cervical cytology screening programmes in middle-income countries: the Chilean experience
    Cecilia Sepulveda
    WHO Programme on Cancer Control, Geneva, Switzerland
    Cancer Detect Prev 29:405-11. 2005
    ..To demonstrate that an effective cervical cancer screening programme based on the Papanicolaou (Pap) smear can be organized in a middle-income country, such as Chile...
  5. ncbi Palliative Care: the World Health Organization's global perspective
    Cecilia Sepulveda
    Program on Cancer Control, World Health Organization, Geneva, Switzerland
    J Pain Symptom Manage 24:91-6. 2002
  6. ncbi Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis
    Gary Michael Ginsberg
    World Health Organization, Health Systems Financing Department, Costs, Effectiveness, Expenditure and Priority Setting Unit, Geneva, Switzerland
    Vaccine 27:6060-79. 2009
    ..Treatment should also be increased where coverage is low...
  7. ncbi Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients
    Ivan Palomo
    Department of Clinical Biochemistry and Immunohematology, Faculty of Health Sciences, University of Talca, Talca, Chile
    J Clin Lab Anal 17:209-15. 2003
    ..Of the HIV-infected patients, 22.2% presented aPL and 9.4% aPlt antibodies. In this study, the presence of aPL and aPlt antibodies was not associated with the development of thrombosis and/or thrombocytopenia...